Entia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual Meeting PORTLAND, Ore., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) was informed by the American Society of Nephrology (“ASN”) that its submission of “late breaking clinical...

Preliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three months PORTLAND, Ore., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported better-than-expected...

Filament BioSolutions Announces Strategic Partnership With Ajinomoto to Develop a Portfolio of Evidence-Based Medical Foods NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Filament BioSolutions Inc., a medical nutrition company, announced today a broad partnership with Ajinomoto North America, Inc., a subsidiary of Ajinomoto...

Pamlab, LLC and Breckenridge Pharmaceutical, Inc. Announce Joint Venture to Provide Authorized Generics on Pamlab Branded Medical Food Products COVINGTON, La. and BOCA RATON, Fla., Oct. 1, 2012 (GLOBE NEWSWIRE) -- Pamlab and Breckenridge have entered into a joint venture for the marketing and distribution of authorized generic versions of...